More drug companies lowered list prices for insulin this week. NPR’s Scott Simon speaks with Kaiser Health News reporter Bram Sable-Smith about what that means for patients.
More drug companies lowered list prices for insulin this week. NPR’s Scott Simon speaks with Kaiser Health News reporter Bram Sable-Smith about what that means for patients.